Researchers explore how sedentary time influences the relationship between daily step count and the risks of mortality and cardiovascular disease.
New CAR T-Cell Therapy Approved for Leukemia
The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults, the agency announced on Friday.